Ethanol Ablation of Neck Metastases from Differentiated Thyroid Carcinoma

Ricardo Paz-Fumagalli1, Xi Li1,2, Robert C Smallridge3

  • 1Division of Interventional Radiology, Mayo Clinic, Jacksonville, Florida.

Insights

Ethanol ablation is a safe and effective minimally invasive treatment for differentiated thyroid cancer with cervical lymph node metastasis, especially for patients unsuitable for surgery.

Area of Science:

  • Oncology
  • Endocrinology
  • Interventional Radiology

Background:

  • Differentiated thyroid cancer frequently metastasizes to cervical lymph nodes.
  • Cervical lymph node resection is standard, but alternatives are needed for specific patient groups.
  • Radioiodine therapy may be ineffective for some metastatic nodes.

Purpose of the Study:

  • To evaluate ethanol ablation as a therapeutic option for cervical lymph node metastases in differentiated thyroid cancer.
  • To compare ethanol ablation with existing treatments like surgery and thermal ablation.

Main Methods:

  • Sonographically guided ethanol ablation procedure.
  • Minimally invasive technique, repeatable with minimal technology and cost.

Main Results:

  • Ethanol ablation is minimally invasive, safe, and easily repeatable.
  • Transient nerve injury is the primary complication, occurring infrequently.
  • Effectiveness is comparable to thermal ablation and approaches surgical outcomes.
  • Therapeutic profile is safer than surgery and thermal ablation.

Conclusions:

  • Ethanol ablation presents a safe and effective alternative for managing differentiated thyroid cancer cervical lymph node metastases.
  • It is particularly suitable for patients with few radioiodine-refractory nodes who are poor surgical candidates.
  • Further well-designed clinical trials are needed to solidify its role in treatment algorithms.

Related Concept Videos